Affirma Biotech
Pre-clinicalAffirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Founded
2018
Focus
Small Molecules
About
Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Funding History
1Total raised: $3.8M
Seed$3.8MUndisclosedNov 15, 2020
Company Info
TypePrivate
Founded2018
LocationBarcelona, Spain
StagePre-clinical
Contact
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile